Showing results (81-90 of 114) with videos related to
Sort By:
Pageof 12
The Journal of Infectious Diseases|December 27, 2021
Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialJiankai Liu, Baoying Huang, Guifan Li, et al.Plos One|March 31, 2017
Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcomeHsiang-Wei Kuo, Chia-Lung Shih, Jieh-Hen Tsung, et al.Expert Review of Vaccines|September 6, 2017
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in ChinaShi-Yuan Wang, Shu-Zhen Liu, Kai Chu, et al.Future Microbiology|July 29, 2022
Comparison of HPV neutralizing and IgG antibodies in unvaccinated female adolescentsXingmei Yao, Kai Chu, Jun Zhao, et al.NPJ Vaccines|March 18, 2025
A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 yearsKai Chu, Jiali Quan, Xiaohui Liu, et al.Human Vaccines & Immunotherapeutics|April 1, 2017
The early-onset febrile reaction following vaccination and associated factors: An exploratory sub-study based on the Ebola vaccine clinical trialQigang Dai, Qi Liang, Yuemei Hu, et al.Journal of Glaucoma|June 25, 2019
Evaluation of a Deep Learning System For Identifying Glaucomatous Optic Neuropathy Based on Color Fundus PhotographsLama A Al-Aswad, Rahul Kapoor, Chia Kai Chu, et al.Vaccine|May 16, 2017
Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffaloHannah Wei Wu, Zhi-Qiang Fu, Ke Lu, et al.The Lancet. Infectious Diseases|December 10, 2021
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trialsGang Zeng, Qianhui Wu, Hongxing Pan, et al.The Oncologist|January 17, 2020
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for ImmunotherapySatya Das, Kristen K Ciombor, Sigurdis Haraldsdottir, et al.Pageof 12